CCEP Fundamental Analysis - COCA-COLA EUROPACIFIC PARTNE

Fundamental Rating

CCEP gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 32 industry peers in the Beverages industry. While CCEP is still in line with the averages on profitability rating, there are concerns on its financial health. While showing a medium growth rate, CCEP is valued expensive at the moment.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year CCEP was profitable.

CCEP had a positive operating cash flow in the past year.

Each year in the past 5 years CCEP has been profitable.

Each year in the past 5 years CCEP had a positive operating cash flow.

1.2 Ratios

With a Return On Assets value of 4.56%, CCEP perfoms like the industry average, outperforming 56.25% of the companies in the same industry.

Looking at the Return On Equity, with a value of 16.70%, CCEP is in the better half of the industry, outperforming 62.50% of the companies in the same industry.

Looking at the Return On Invested Capital, with a value of 7.00%, CCEP is in line with its industry, outperforming 50.00% of the companies in the same industry.

The Average Return On Invested Capital over the past 3 years for CCEP is below the industry average of 11.57%.

		Industry Rank	Sector Rank
ROA	4.56%
ROE	16.7%
ROIC	7%

ROA(3y)5.14%

ROA(5y)4.27%

ROE(3y)19.29%

ROE(5y)16.02%

ROIC(3y)7.84%

ROIC(5y)6.6%

1.3 Margins

Looking at the Profit Margin, with a value of 6.94%, CCEP is in line with its industry, outperforming 56.25% of the companies in the same industry.

CCEP's Profit Margin has declined in the last couple of years.

CCEP has a Operating Margin (10.46%) which is comparable to the rest of the industry.

CCEP's Operating Margin has declined in the last couple of years.

Looking at the Gross Margin, with a value of 35.31%, CCEP is doing worse than 81.25% of the companies in the same industry.

CCEP's Gross Margin has been stable in the last couple of years.

		Industry Rank	Sector Rank
OM	10.46%
PM (TTM)	6.94%
GM	35.31%

OM growth 3Y1.73%

OM growth 5Y-1.57%

PM growth 3Y-0.93%

PM growth 5Y-5.22%

GM growth 3Y-1.58%

GM growth 5Y-1.5%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), CCEP is creating some value.

CCEP has more shares outstanding than it did 1 year ago.

Compared to 5 years ago, CCEP has more shares outstanding

Compared to 1 year ago, CCEP has an improved debt to assets ratio.

2.2 Solvency

An Altman-Z score of 2.19 indicates that CCEP is not a great score, but indicates only limited risk for bankruptcy at the moment.

The Altman-Z score of CCEP (2.19) is comparable to the rest of the industry.

CCEP has a debt to FCF ratio of 5.34. This is a neutral value as CCEP would need 5.34 years to pay back of all of its debts.

The Debt to FCF ratio of CCEP (5.34) is better than 75.00% of its industry peers.

A Debt/Equity ratio of 1.17 is on the high side and indicates that CCEP has dependencies on debt financing.

Looking at the Debt to Equity ratio, with a value of 1.17, CCEP is doing worse than 71.88% of the companies in the same industry.

		Industry Rank	Sector Rank
Debt/Equity	1.17
Debt/FCF	5.34
Altman-Z	2.19

ROIC/WACC0.91

WACC7.67%

2.3 Liquidity

A Current Ratio of 0.81 indicates that CCEP may have some problems paying its short term obligations.

Looking at the Current ratio, with a value of 0.81, CCEP is doing worse than 78.13% of the companies in the same industry.

CCEP has a Quick Ratio of 0.81. This is a bad value and indicates that CCEP is not financially healthy enough and could expect problems in meeting its short term obligations.

CCEP has a Quick ratio of 0.62. This is in the lower half of the industry: CCEP underperforms 68.75% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	0.81
Quick Ratio	0.62

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The earnings per share for CCEP have decreased strongly by -15.31% in the last year.

The Earnings Per Share has been growing slightly by 5.80% on average over the past years.

CCEP shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 11.67%.

CCEP shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 11.21% yearly.

EPS 1Y (TTM)-15.31%

EPS 3Y12.68%

EPS 5Y5.8%

EPS Q2Q%-24.06%

Revenue 1Y (TTM)11.67%

Revenue growth 3Y14.09%

Revenue growth 5Y11.21%

Sales Q2Q%13.78%

3.2 Future

The Earnings Per Share is expected to grow by 9.28% on average over the next years. This is quite good.

CCEP is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.08% yearly.

EPS Next Y5.43%

EPS Next 2Y7.31%

EPS Next 3Y7.85%

EPS Next 5Y9.28%

Revenue Next Year3.16%

Revenue Next 2Y3.31%

Revenue Next 3Y3.5%

Revenue Next 5Y3.08%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 26.61, which means the current valuation is very expensive for CCEP.

CCEP's Price/Earnings ratio is in line with the industry average.

The average S&P500 Price/Earnings ratio is at 27.30. CCEP is around the same levels.

With a Price/Forward Earnings ratio of 19.35, CCEP is valued on the expensive side.

CCEP's Price/Forward Earnings ratio is in line with the industry average.

CCEP's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 21.76.

		Industry Rank	Sector Rank
PE	26.61
Fwd PE	19.35

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as CCEP.

Compared to the rest of the industry, the Price/Free Cash Flow ratio of CCEP indicates a somewhat cheap valuation: CCEP is cheaper than 78.13% of the companies listed in the same industry.

		Industry Rank	Sector Rank
P/FCF	17.62
EV/EBITDA	15.26

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates CCEP does not grow enough to justify the current Price/Earnings ratio.

PEG (NY)4.9

PEG (5Y)4.59

EPS Next 2Y7.31%

EPS Next 3Y7.85%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 2.35%, CCEP has a reasonable but not impressive dividend return.

CCEP's Dividend Yield is a higher than the industry average which is at 3.00.

Compared to an average S&P500 Dividend Yield of 2.35, CCEP has a dividend comparable with the average S&P500 company.

		Industry Rank	Sector Rank
Dividend Yield	2.35%

5.2 History

The dividend of CCEP is nicely growing with an annual growth rate of 9.91%!

CCEP has paid a dividend for at least 10 years, which is a reliable track record.

CCEP has not decreased its dividend in the last 3 years.

Dividend Growth(5Y)9.91%

Div Incr Years4

Div Non Decr Years4

5.3 Sustainability

64.17% of the earnings are spent on dividend by CCEP. This is not a sustainable payout ratio.

The dividend of CCEP is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.

DP64.17%

EPS Next 2Y7.31%

EPS Next 3Y7.85%

More info and screens

Find the best dividend stocks

Show peers with best dividend

COCA-COLA EUROPACIFIC PARTNE

NASDAQ:CCEP (7/11/2025, 8:00:02 PM)

After market: 95.52 0 (0%)

95.52

+0.07 (+0.07%)

Chartmill FA Rating

GICS SectorConsumer Staples

GICS IndustryGroupFood, Beverage & Tobacco

GICS IndustryBeverages

Earnings (Last)04-29 2025-04-29

Earnings (Next)N/A N/A

Inst Owners37.53%

Inst Owner Change0%

Ins Owners0.22%

Ins Owner ChangeN/A

Market Cap43.67B

Analysts77.27

Price Target96.23 (0.74%)

Short Float %1.97%

Short Ratio2.36

Dividend

		Industry Rank	Sector Rank
Dividend Yield	2.35%

Yearly Dividend2.31

Dividend Growth(5Y)9.91%

DP64.17%

Div Incr Years4

Div Non Decr Years4

Ex-Date05-16 2025-05-16 (0.9)

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0%

PT rev (3m)3.77%

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)-0.06%

EPS NY rev (3m)-1.32%

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)-0.08%

Revenue NY rev (3m)-0.95%

Valuation

		Industry Rank	Sector Rank
PE	26.61
Fwd PE	19.35
P/S	1.83
P/FCF	17.62
P/OCF	12.21
P/B	4.4
P/tB	N/A
EV/EBITDA	15.26

EPS(TTM)3.59

EY3.76%

EPS(NY)4.94

Fwd EY5.17%

FCF(TTM)5.42

FCFY5.68%

OCF(TTM)7.82

OCFY8.19%

SpS52.22

BVpS21.69

TBVpS-22.86

PEG (NY)4.9

PEG (5Y)4.59

Profitability

		Industry Rank	Sector Rank
ROA	4.56%
ROE	16.7%
ROCE	9.32%
ROIC	7%
ROICexc	7.57%
ROICexgc	42.27%
OM	10.46%
PM (TTM)	6.94%
GM	35.31%
FCFM	10.38%

ROA(3y)5.14%

ROA(5y)4.27%

ROE(3y)19.29%

ROE(5y)16.02%

ROIC(3y)7.84%

ROIC(5y)6.6%

ROICexc(3y)8.71%

ROICexc(5y)7.37%

ROICexgc(3y)64.53%

ROICexgc(5y)51.3%

ROCE(3y)10.42%

ROCE(5y)8.8%

ROICexcg growth 3Y8.99%

ROICexcg growth 5Y7.35%

ROICexc growth 3Y14.53%

ROICexc growth 5Y1.38%

OM growth 3Y1.73%

OM growth 5Y-1.57%

PM growth 3Y-0.93%

PM growth 5Y-5.22%

GM growth 3Y-1.58%

GM growth 5Y-1.5%

F-Score5

Asset Turnover0.66

Health

		Industry Rank	Sector Rank
Debt/Equity	1.17
Debt/FCF	5.34
Debt/EBITDA	3.24
Cap/Depr	100.64%
Cap/Sales	4.59%
Interest Coverage	8.59
Cash Conversion	99.67%
Profit Quality	149.65%
Current Ratio	0.81
Quick Ratio	0.62
Altman-Z	2.19

F-Score5

WACC7.67%

ROIC/WACC0.91

Cap/Depr(3y)92.36%

Cap/Depr(5y)78.04%

Cap/Sales(3y)4.17%

Cap/Sales(5y)3.92%

Profit Quality(3y)141.19%

Profit Quality(5y)162.2%

High Growth Momentum

Growth

EPS 1Y (TTM)-15.31%

EPS 3Y12.68%

EPS 5Y5.8%

EPS Q2Q%-24.06%

EPS Next Y5.43%

EPS Next 2Y7.31%

EPS Next 3Y7.85%

EPS Next 5Y9.28%

Revenue 1Y (TTM)11.67%

Revenue growth 3Y14.09%

Revenue growth 5Y11.21%

Sales Q2Q%13.78%

Revenue Next Year3.16%

Revenue Next 2Y3.31%

Revenue Next 3Y3.5%

Revenue Next 5Y3.08%

EBIT growth 1Y-4.98%

EBIT growth 3Y16.06%

EBIT growth 5Y9.46%

EBIT Next Year43.62%

EBIT Next 3Y17.56%

EBIT Next 5Y12.75%

FCF growth 1Y6.42%

FCF growth 3Y8.29%

FCF growth 5Y10.26%

OCF growth 1Y9.09%

OCF growth 3Y13.08%

OCF growth 5Y9.96%

COCA-COLA EUROPACIFIC PARTNE (CCEP) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

5.2 History

5.3 Sustainability

More info and screens